Skip to content

Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.

Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01910935
Enrollment
224
Registered
2013-07-30
Start date
2013-07-31
Completion date
2014-04-30
Last updated
2014-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Physical activity, Hypertension, Scheme reference, Primary care

Brief summary

The purpose of this study is to evaluate the effectiveness of a program to increase the physical activity of hypertensive patients using medical services and sports facilities of the Mexican Social Security Institute. The primary hypothesis to be proven is: The intervention will increase the proportion of hypertensive patients complying the physical activity minimum at week to get benefits on health in 20%, compare to patients in control group.

Detailed description

Secondary Hypothesis: The intervention achieved a significant change in the group of hypertensive patients in the following variables: 1. Decreased levels of systolic and diastolic blood pressure, biochemical markers such as total cholesterol, triglycerides and fasting blood glucose and increased HDL cholesterol. 2. Increase muscular endurance and cardio-respiratory capacity according to the categories of risk stratification. 3. Decreased body weight, body mass index and waist circumference.

Interventions

BEHAVIORALPhysical activity prescription to develop program in group.

Overall the intervention involves a medical reference in primary care (PHC) to hypertensive patients (during routine consultation) to assist the sports facilities of the same Institute, to develop a group program of physical activity which will last 24 weeks. Led by the trained staff in physical activity to patients with chronic diseases.

Sponsors

Coordinación de Investigación en Salud, Mexico
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed with high blood pressure \<5 years of evolution and / or without use of drug therapy to treat that condition; * with low levels of physical activity (PA) or physically inactive (less than 150 minutes of PA at week, intensity moderate to vigorous); * with availability to PA practice or considering begin to PA practice within the next six months (contemplation or preparation stages of the Transtheoretical Model). * Without cardiovascular risk (assessed previously); * Without physical or mobility problems that impede PA practice; * Willingness to participate in the study, fulfill with outlined activities to develop the proposal.

Exclusion criteria

* high-risk patients according to the risk stratification of the American College of Sports Medicine; * fulfill the high recommendation of physical activity (more than 300 minutes per week of moderate to vigorous intensity);

Design outcomes

Primary

MeasureTime frameDescription
Physical activity. Level of physical activity between intervention and control groups.24 weeksThe length of the intervention is 24 weeks, the control group will be followed for 24 weeks also. The outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention. The intervention will be effective if the difference in the percent of population (complying the minimum recommended of physical activity) among control and intervention groups is at least of 20%.

Secondary

MeasureTime frameDescription
Blood pressure24 weeksBlood pressure among intervention and control groups, at the three moments of the study: basal measurement, 24 weeks (end of the intervention) and 36 weeks. The outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention.

Other

MeasureTime frameDescription
Composite measure of biochemical markers: total cholesterol, triglycerides and fasting blood glucose24 weeksBiochemical markers (total cholesterol, triglycerides and fasting blood glucose) among intervention and control groups, at the three moments of the study: basal measurement, 24 weeks (end of the intervention) and 36 weeks. The secondary outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026